Effect of US contrast agents on spectral velocities: In vitro evaluation

Radiology

Volumn 211, Issue 2, 1999, Pages 427-431

  Melany, Michelle L ^a   Grant, Edward C ^b   Farooki, Shella ^a   McElroy, David ^a   Kimme Smith, Carolyn ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Blood vessels, stenosis or obstruction; Blood, flow dynamics; Ultrasound (US), contrast media; Ultrasound (US), Doppler studies

Indexed keywords

ECHO CONTRAST MEDIUM; HEXANE; PERFLUOROPENTANE; SHU 508;

ARTICLE; CARDIOVASCULAR SYSTEM; DIAGNOSTIC ACCURACY; DOPPLER FLOWMETRY; ECHOGRAPHY; EMULSION; FLOW MEASUREMENT; MODEL; NONHUMAN; PRIORITY JOURNAL; SIGNAL NOISE RATIO; SPECTROSCOPY; STENOSIS; SWINE; VELOCITY;

EID: 0033004450     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.211.2.r99ma56427     Document Type: Article

References (18)

1. Needleman L, Forsberg F. Contrast agents in ultrasound. Ultrasound Q 1996; 13:121-138.
2. Melany ML, Grant EG. Clinical experience with sonographic contrast agents. Semin Ultrasound CT MR 1997; 18:3-12.
3. Cosgrove D. Why do we need contrast agents for ultrasound? Clin Radiol 1996; 51(suppl 1):1-4.
4. Bauer A, Becker G, Krone A, Frohlich T, Bogdahn U. Transcranial duplex sonography using ultrasound contrast enhancers. Clin Radiol 1996; 51(suppl 1): 19-23.
5. Melany ML, Grant EG, Duerinckx AJ, Watts TM, Levine BS. Ability of a phase shift US contrast agent to improve imaging of the main renal arteries. Radiology 1997; 205:147-152.
6. Petrick J, Zomack M, Schlief R. An investigation of the relationship between ultrasound echo enhancement and Doppler frequency shift using a pulsatile arterial flow phantom. Invest Radiol 1997; 32:225-235.
7. Forsberg F, Liu JB, Burns PN, Merton DA, Goldberg BB. Artifacts in ultrasonic contrast agent studies. J Ultrasound Med 1994; 13:357-365.
8. Goldberg BB, Liu JB, Forsberg F. Ultrasound contrast agents: a review. Ultrasound Med Biol 1994; 20:319-333.
9. Cohen J, Bruns D, Hausner E, et al. A multicenter trial comparing FS069 and Albunex for left ventricular endocardial border delineation (abstr). J Am Coll Cardiol 1997;29(supplA):519A.
10. Sponheim N, Myhrum M. An in vitro study on the influence of limited frequency resolution on contrast agent-enhanced Doppler signals. Ultrasonics 1996; 34:599-601.
11. Sitzer M, Furst G, Siebler M, Steinmetz H. Usefulness of an intravenous contrast medium in the characterization of high-grade internal carotid stenosis with color Doppler-assisted duplex imaging. Stroke 1994; 25:385-389.
12. Needleman L, Goldberg BB, Feld RI, et al. Evaluation of arterial disease in humans using an ultrasound contrast agent (abstr). J Ultrasound Med 1995; 14(suppl):48.
13. Tessler FN, Kimme-Smith C, Sutherland ML, Schiller VL, Perrella RR, Grant EG. Inter- and intra-observer variability of Doppler peak velocity measurements: an in-vitro study. Ultrasound Med Biol 1990; 16:653-657.
14. Whyman MR, Hoskins PR, Leng GC, et al. Accuracy and reproducibility of duplex ultrasound imaging in a phantom model of femoral artery stenosis. J Vasc Surg 1993; 17:524-530.
15. Moriyasu F, Ban N, Nishida O, Nakamura T, Miyake T. Clinical application of an ultrasonic duplex system in the quantitative measurement of portal blood flow. JCU 1986; 14:579-588.
16. Zoli M, Marchesini G, Cordiani MR, et al. Echo-Doppler measurement of splanchnic blood flow in control and cirrhotic subjects. JCU 1986; 14:429-435.
17. Burns PN. The physical principles of Doppler and spectral analysis. JCU 1987; 15: 567-590.
18. Gill RW. Measurement of blood flow by ultrasound: accuracy and sources of error. Ultrasound Med Biol 1985; 11:625-641.